Klea Holding (ALKLH) | Financial Analysis & Statements
Klea Holding Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2018Income Metrics
EPS (Diluted)
€0.00
Balance Sheet Metrics
Total Assets
36.6M
Total Liabilities
9.1M
Shareholders Equity
27.5M
Debt to Equity
0.33
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Klea Holding Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 17.3M | 13.7M | 14.4M | 7.2M | 19.0M |
| Cost of Goods Sold | 9.0M | 7.4M | 11.2M | 7.9M | 22.7M |
| Gross Profit | 8.3M | 6.3M | 3.2M | -715.0K | -3.8M |
| Gross Margin % | 47.8% | 46.0% | 22.2% | -10.0% | -19.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | - | 23.0K | 801.0K | 832.0K | -786.0K |
| Total Operating Expenses | 0 | 23.0K | 801.0K | 832.0K | -786.0K |
| Operating Income | 1.9M | 952.0K | -3.9M | -3.7M | -6.6M |
| Operating Margin % | 11.3% | 6.9% | -27.1% | -51.3% | -34.8% |
| Non-Operating Items | |||||
| Interest Income | 275.0K | 112.0K | 4.0K | 12.0K | - |
| Interest Expense | 758.0K | 1.2M | 182.0K | 618.0K | 382.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 1.5M | 1.5M | -5.1M | -4.2M | -5.2M |
| Income Tax | 267.0K | -37.0K | 113.0K | 142.0K | -164.0K |
| Effective Tax Rate % | 17.8% | -2.4% | 0.0% | 0.0% | 0.0% |
| Net Income | 1.4M | 902.0K | -5.3M | -4.5M | -5.2M |
| Net Margin % | 8.1% | 6.6% | -36.5% | -62.1% | -27.1% |
| Key Metrics | |||||
| EBITDA | 3.8M | 4.2M | -1.2M | -2.9M | -6.7M |
| EPS (Basic) | €0.00 | €0.00 | €-0.02 | €-0.03 | €-0.20 |
| EPS (Diluted) | €0.00 | €0.00 | €-0.02 | €-0.03 | €-0.20 |
| Basic Shares Outstanding | 307514314 | 294356419 | 263850000 | 138087389 | 25382874 |
| Diluted Shares Outstanding | 307514314 | 294356419 | 263850000 | 138087389 | 25382874 |
Income Statement Trend
Klea Holding Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 3.3M | 3.0M | 2.4M | 6.6M | 779.0K |
| Short-term Investments | - | - | - | 7.0K | 31.0K |
| Accounts Receivable | 1.7M | 1.2M | 1.8M | 4.6M | 252.0K |
| Inventory | 19.0K | 0 | 658.0K | 1.4M | 1.3M |
| Other Current Assets | 2.0K | - | 410.0K | 203.0K | 330.0K |
| Total Current Assets | 7.1M | 5.3M | 7.0M | 16.0M | 5.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 8.2M | 7.3M | 13.0M | 8.5M | 1.0M |
| Goodwill | 49.7M | 49.5M | 38.3M | 44.1M | 541.0K |
| Intangible Assets | 539.0K | 356.0K | 374.0K | 90.0K | 97.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | 1.0K | -1.0K | -101.0K | 1.0K |
| Total Non-Current Assets | 30.7M | 31.3M | 29.1M | 28.1M | 832.0K |
| Total Assets | 37.8M | 36.6M | 36.1M | 44.1M | 5.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.6M | 2.1M | 3.0M | 17.3M | 5.2M |
| Short-term Debt | 1.8M | 287.0K | 127.0K | 5.0M | 2.0K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 310.0K | 13.0M | 69.0K |
| Total Current Liabilities | 5.3M | 3.1M | 5.5M | 24.2M | 8.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.1M | 7.6M | 5.5M | 0 | 13.0K |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | -1.0K | -1.0K | 1.2M | 406.0K |
| Total Non-Current Liabilities | 4.7M | 8.8M | 6.3M | 5.8M | 1.5M |
| Total Liabilities | 10.0M | 11.8M | 11.8M | 30.0M | 10.3M |
| Equity | |||||
| Common Stock | 3.1M | 2.9M | 2.9M | 1.4M | 20.3M |
| Retained Earnings | 1.4M | 902.0K | -5.3M | -4.5M | -36.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 27.8M | 24.7M | 24.3M | 14.1M | -4.4M |
| Key Metrics | |||||
| Total Debt | 5.9M | 7.9M | 5.6M | 5.0M | 15.0K |
| Working Capital | 1.9M | 2.2M | 1.5M | -8.2M | -3.7M |
Balance Sheet Composition
Klea Holding Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.2M | 902.0K | -5.3M | -4.5M | -5.2M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | 769.0K | -1.3M | -5.3M | -4.5M | -5.2M |
| Investing Activities | |||||
| Capital Expenditures | -626.0K | -1.8M | -5.5M | -171.0K | 3.1M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -626.0K | -1.6M | -17.5M | -15.0M | 3.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 2.0M | 2.4M | 12.2M | 26.0M | 1.6M |
| Debt Repayment | -3.9M | -1.3M | -650.0K | -713.0K | -1.6M |
| Financing Cash Flow | -199.0K | 1.0M | 14.8M | 27.2M | 0 |
| Free Cash Flow | 166.0K | -1.5M | -7.3M | -6.7M | -11.1M |
| Net Change in Cash | -56.0K | -1.8M | -8.0M | 7.7M | -2.1M |
Cash Flow Trend
Klea Holding Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.58
Price to Book
1.98
Price to Sales
2.59
Profitability Ratios
Profit Margin
11.89%
Operating Margin
15.59%
Return on Equity
9.14%
Return on Assets
5.41%
Financial Health
Current Ratio
1.64
Debt to Equity
18.40
Beta
-0.60
Per Share Data
EPS (TTM)
€0.01
Book Value per Share
€0.09
Revenue per Share
€0.07
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALKLH | 54.0M | 17.58 | 1.98 | 9.14% | 11.89% | 18.40 |
| Eurofins Scientific | 10.8B | 24.24 | 3.08 | 9.50% | 6.51% | 96.84 |
| bioMérieux S.A | 8.4B | 21.24 | 2.04 | 9.54% | 9.77% | 11.24 |
| Eurofins Cerep SAS | 79.7M | 12.94 | - | 8.74% | 15.86% | 0.10 |
| Predilife S.A | 12.2M | - | - | -4,653.75% | 97.76% | -1.15 |
| Lumibird S.A | 540.6M | 38.59 | 2.64 | 6.93% | 6.13% | 70.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.